NCT03107832

Brief Summary

CONTEXT AND AIMS: The aim of the study is to compare patients satisfaction of thoracic epidural and general anesthesia procedures in patients undergoing elective laparoscopic cholecystectomy. SETTINGS AND DESIGN: This comparative randomized study was conducted Abant Izzet Baysal University hospital between October 2012 and 2014.Forty-five patients who were under American Society of Anesthesiologists I-II classification and were scheduled for elective laparoscopic cholecystectomy were included in the study. SUBJECTS AND METHODS: All participant was separated, two group. In epidural anesthesia group(Group E), a catheter was installed and received 20 mg lidocaine hydrochloride, 15 mg bupivacaine, and 25 mg fentanyl citrate adjusted to 10 cc with normal saline to be injected by the epidural catheter. Bispectral index -controlled sedation was provided. In general anesthesia group(Group G), and induction was managed using 1.5 mg/kg fentanyl and 2 mg/kg propofol; 0.5 mg/kg rocuronium and sevoflurane in a 50% oxygen/air mixture was used. Blood gas analysis monitoring was performed in the 30th minute before and after pneumoperitoneum. Surgical satisfaction was recorded after pneumoperitoneum. After the operation, 75 mg diclofenac sodium was applied for patients with Numeric Rating Scale scores higher than 4. STATISTICAL ANALYSIS USED:Data analysis was performed using the Statistical Package for the Social Sciences version 18 software (SPSS, Chicago, IL, US). Descriptive variables, such as age, ASA classification, weight, height, mean arterial pressure (MAP), HR, and duration of surgery, are given as mean ± standard deviation, and an independent sample t-test (normal distribution) as well as a Mann-Whitney U test (not a normal distribution) were used for continuous variables. To compare the normal and abnormal distributions in the groups, simple t-test, and Wilcoxon test was used, respectively. The results were considered statistically significant at p-values \<0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 30, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2013

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2013

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 11, 2017

Completed
Last Updated

April 12, 2017

Status Verified

April 1, 2017

Enrollment Period

8 months

First QC Date

March 29, 2017

Last Update Submit

April 11, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • patient satisfaction

    four level patient satisfaction scale

    after postoperative 24 hour

Secondary Outcomes (8)

  • mean arterial pressure

    intaoperative 0, 5, 10, 15, 30, and 45 minutes

  • heart rate

    intaoperative 0, 5, 10, 15, 30, and 45 minutes

  • Blood gas analysis

    intaoperative 0 and 35 minutes

  • Hypotension

    During the operation

  • Bradycardia

    During the operation

  • +3 more secondary outcomes

Study Arms (2)

general anesthesia

ACTIVE COMPARATOR

In general anesthesia group (Group G), and induction was managed using 1.5 mg/kg fentanyl and 2 mg/kg propofol; 0.5 mg/kg rocuronium and sevoflurane in a 50% oxygen /air mixture was used. Blood gas analysis monitoring was performed in the 30th minute before and after pneumoperitoneum

Procedure: thoracic epidural anesthesia procedure

thoracic epidural anesthesia

EXPERIMENTAL

In epidural anesthesia group(Group E), a catheter was installed and received 20 mg lidocaine hydrochloride, 15 mg bupivacaine, and 25 mg fentanyl citrate adjusted to 10 cc with normal saline to be injected by the epidural catheter. Bi-spectral index -controlled sedation was provided

Procedure: thoracic epidural anesthesia procedure

Interventions

general anesthesia procedure

general anesthesiathoracic epidural anesthesia

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists I-II classification ,
  • Elective laparoscopic cholecystectomy ,
  • Ages of 18 and 75

You may not qualify if:

  • allergies against any of the drugs to be used in the study,
  • current pregnancy,
  • severe cardiac, renal, and liver diseases,
  • previous upper abdominal surgery,
  • acute cholangitis,
  • a body mass index \>32 kg m2,
  • contraindications for epidural anesthesia and elective surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abant Izzet Baysal University Medical School,

Bolu, Bolu, 14280, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

March 29, 2017

First Posted

April 11, 2017

Study Start

December 30, 2012

Primary Completion

August 25, 2013

Study Completion

December 29, 2013

Last Updated

April 12, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations